Bone Disease clinical trials at UCSF
1 in progress, 0 open to eligible people
Sorry, not currently recruiting here
This is a prospective, multicenter phase II study designed to evaluate the outcomes of patients with bone marrow failure diseases (BMFD) undergoing HLA-matched related, HLA-matched unrelated, or single HLA-class 1 allele or HLA-DQB1 antigen or allele mismatched unrelated hematopoietic cell transplantation (HCT) using treosulfan-based conditioning.
San Francisco, California and other locations